Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics by Jessica Waters, Andrew F. Shorr

Get full text

Going Viral—RSV as the Neglected Adult Respiratory Virus by Bethany Busack, Andrew F. Shorr

Get full text

Statistics on steroids: How recognizing competing risks gets us closer to the truth about COVID-19-associated VAP by Andrew F. Shorr, Marya D. Zilberberg

Get full text

Critical Parameters for the Development of Novel Therapies for Severe and Resistant Infections—A Case Study on CAL02, a Non-Traditional Broad-Spectrum Anti-Virulence Drug by Samareh Azeredo da Silveira, Andrew F. Shorr

Get full text

At the Intersection of Critical Care and Infectious Diseases: The Year in Review by Sarah R. Sabo, Aarthi Venkatramanan, Andrew F. Shorr

Get full text

Respiratory Viruses in Nosocomial Pneumonia: An Evolving Paradigm by Marya D. Zilberbeg, Imran Khan, Andrew F. Shorr

Get full text

Bloodstream Infection in the Intensive Care Unit: Evolving Epidemiology and Microbiology by Carly Munro, Marya D. Zilberberg, Andrew F. Shorr

Get full text

Diagnostics and epidemiology in ventilator-associated pneumonia by Andrew F. Shorr, Chee M. Chan, Marya D. Zilberberg

Get full text

Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005 by Marya D. Zilberberg, Andrew F. Shorr, Marin H. Kollef

Get full text

Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005 by Marya D. Zilberberg, Andrew F. Shorr, Marin H. Kollef

Get full text

Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP). by Andrew F Shorr, Laura A Puzniak, Pinaki Biswas, Michael S Niederman

Get full text

Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016–2018 by Marya D. Zilberberg, Brian H. Nathanson, Kate Sulham, Andrew F. Shorr

Get full text

Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004–2013 by Marya D. Zilberberg, Rachel Harrington, James R. Spalding, Andrew F. Shorr

Get full text

Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013–2018: a retrospective cohort study by Marya D. Zilberberg, Brian H. Nathanson, Kate Sulham, Andrew F. Shorr

Get full text

Daily cost of delay to adequate antibiotic treatment among patients surviving a hospitalization with community-onset Acinetobacter baumannii pneumonia or sepsis by Marya D. Zilberberg, Brian H. Nathanson, Kate Sulham, Weihong Fan, Andrew F. Shorr

Get full text

30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study by Marya D. Zilberberg, Brian H. Nathanson, Kate Sulham, Weihong Fan, Andrew F. Shorr

Get full text

Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis by Marya D. Zilberberg, Brian H. Nathanson, Kate Sulham, Weihong Fan, Andrew F. Shorr

Get full text

The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) ba... by Marya D. Zilberberg, Brian H. Nathanson, Laura A. Puzniak, Ryan J. Dillon, Andrew F. Shorr

Get full text

Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014–2019 by Marya D. Zilberberg, Brian H. Nathanson, Laura A. Puzniak, Noah W. D. Zilberberg, Andrew F. Shorr

Get full text

Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014-2019. by Marya D Zilberberg, Brian H Nathanson, Laura A Puzniak, Noah W D Zilberberg, Andrew F Shorr

Get full text